Albemarle Corporation (ALB), known for specialty chemicals, faces anticipation for its Q2 earnings announcement on Jul. 30. Analysts predict a loss of $0.84 per share, contrasting with previous profits. ALB stock has underperformed, down 27.5% in the past year, attributed to challenges in energy storage and global trade volatility.

Despite underperformance, analysts remain moderately bullish on ALB stock, with a majority suggesting a “Hold” rating. The average price target is $78.92, indicating an 11.2% potential upside. ALB’s Q1 results showed a 20.9% drop in revenue and a 169.2% decrease in adjusted EPS. Future expectations predict an EPS increase in fiscal 2026.

The main reasons for ALB’s recent struggles include decreased pricing in the energy storage segment and reduced volumes in the Ketjen segment. Global trade policy fluctuations under Trump’s administration have added to the company’s challenges. ALB’s performance underscores the impact of external factors on its operations and stock value.

Read more at Yahoo Finance: What You Need to Know Ahead of Albemarle’s Earnings Release